Rexahn Pharmaceuticals, Inc. (REXN)

[Crozz]

Totally agreed! It's pretty sad what this stock has become. If mgmt wants to increase the A/S, then offer a 2:1 split and let investors keep what little they have left. If they would have doubled the A/S at this last meeting and left all else the same, this thing would be back in the pennies. There is ZERO buying pressure. The potential is here for blockbuster cancer drugs, but the investors are not paying attention. A few years ago, someone on another board told me that it's about 5 years too early to have money in this stock. He was right and I should have listened.